Skip to content

Homoeopathy and Atopic Dermatitis(AD) in Paediatric age group.

Role of individualized Homoeopathic Medicine in reducing Serum Immunoglobulin-E(S. Ig-E) in cases of Atopic Dermatitis in paediatric age Group: A Single Group Pre-Test Post-Test Interventional Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/054835
Enrollment
50
Registered
2023-07-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: Individualized Homoeopathic medicine: Administering indicated homoeopathic medicine for a period of 6 months, as decided appropriate to the case. Potency: Medicine will be dispensed in

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patientâ??s parents willing to give written informed consent and the patients willing to give verbal assent (children aged between 7-12 years) and or written assent (children aged between 12-17years). 2. Patient in the age group of 4-17 years. 3. Patients of all sexes. 4. Patients fulfilling Hanifin and Rajka diagnostic criteria. 5. Patients already undergoing oral/topical conventional therapy for Atopic dermatitis maybe recruited after a washout period of 1 month.

Exclusion criteria

Exclusion criteria: 1. Complicated cases of atopic dermatitis. 2. Critically ill patient, immune-compromised patient. 3. Patient suffering from any other systemic diseases. 4. Diagnosed cases of unstable mental or psychiatric illness. 5. Patient or Parents of patient unwilling to give consent. 6. Patient having any substance abuse.

Design outcomes

Primary

MeasureTime frame
Serum Immunoglobulin E (S IgE)Timepoint: Baseline & after 6 months of treatment

Secondary

MeasureTime frame
Childrenâ??s Dermatological Life Quality Index (CDLQI)Timepoint: Baseline & after 6 months of treatment;Modified Naranjo Criteria for Homoeopathy(MONARCH)Timepoint: At the end of treatment (6th month);SCORAD IndexTimepoint: Baseline & after 6 months of treatment

Countries

India

Contacts

Public ContactDr Shishir Kumar Singh

National Institute of Homoeopathy

drshishirsinghmd@gmail.com8240898749

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026